Smith Patrick W

EDGAR CIK 0001167028

Oncocyte Corp - OCX

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
8
$2.45 M
1,188,987 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/07/2025
02/11/2025
Buy
1,077,600 @ $2.05
 $2,209,080 2,872,671 (60.03%) Indirect - See footnote
02/04/2025
02/04/2025
Buy
25 @ $2.02
 $50 1,795,071 (0.00%) Indirect - See footnote
01/31/2025
02/04/2025
Buy
890 @ $2.01
 $1,789 1,795,046 (0.05%) Indirect - See footnote
01/30/2025
01/31/2025
Buy
318 @ $2.01
 $639 1,794,156 (0.02%) Indirect - See footnote
01/29/2025
01/31/2025
Buy
3,880 @ $2.01
 $7,799 1,793,838 (0.22%) Indirect - See footnote
01/14/2025
01/15/2025
Buy
10,386 @ $2.15
 $22,323 1,789,958 (0.58%) Indirect - See footnote
01/13/2025
01/15/2025
Buy
5,669 @ $2.08
 $11,792 1,779,572 (0.32%) Indirect - See footnote
12/26/2024
12/27/2024
Buy
90,219 @ $2.13
 $192,166 1,773,903 (5.36%) Indirect - See footnote

Axon Enterprise, Inc. - AXON

  1. Manufacturing
  2. Fabricated Metal Products
  3. Ordnance & Accessories, (no Vehicles/guided Missiles)
CEO Director
CHIEF EXECUTIVE OFFICER
Direct Buys
0
$0
0 Shares
Direct Sells
1
($1.93) M
-4,767 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/03/2024
10b5-1
10/04/2024
Sell
-4,767 @ $404.14
 ($1,926,545) 2,925,060 (-0.16%) Direct